Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: tocilizumab

Key Research in Vasculitis Encapsulated

Philip Seo, MD, MHS  |  

Summaries of selected research abstracts on the assessment & management of systemic vasculitis from ACR Convergence 2024.

Case Report: Giant Cell Arteritis Presenting with Scalp Necrosis

Jude Al Qaqaa, MD, Vladimir Falb, DO, & Kaitlyn Buzard, DO  |  

Giant cell arteritis (GCA), is an inflammatory vasculitis that involves large- and mediumsized arteries, most commonly the cranial branches of the carotid artery.1 It is seen in individuals 50 years and older.1 The most typical manifestation is new-onset headache with scalp tenderness and jaw claudication. 2 The most feared complication associated with GCA is permanent…

Trends in the Use of DMARDs for Patients with JIA

  |  

Yalamanchili et al. describe how trends in disease-modifying anti-rheumatic drug (DMARD) use have evolved for insured, U.S. patients with juvenile idiopathic arthritis. Overall, the study found that from 2000 to 2022 in this patient population the use of biologic and targeted synthetic DMARDs rose, while the use of conventional synthetic DMARDs declined.

Black family, healthcare and a pediatrician talking to a patient in the hospital for medical child care. Kids, trust or medicine and a nurse consulting a boy with his mother in the clinic for health.

Youthful Exuberance: The Year in Review for Pediatric Rheumatology

  |  

WASHINGTON, D.C.—It is no small task to summarize an entire year’s worth of research accomplishments in any field of medicine, let alone one as complex as rheumatology. At ACR Convergence 2024, the Pediatric Year in Review not only provided a thoughtful summary, but also grouped advances along several different themes. Immune Health & More Jessica…